Bismar TA - Search Results

1

ERG expression in prostate cancer: biological relevance and clinical implication.

Abou-Ouf H, Zhao L, Bismar TA. Abou-Ouf H, et al. Among authors: bismar ta. J Cancer Res Clin Oncol. 2016 Aug;142(8):1781-93. doi: 10.1007/s00432-015-2096-x. Epub 2015 Dec 28. J Cancer Res Clin Oncol. 2016. PMID: 26711283 Review.

2

Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.

Mosquera JM, Perner S, Genega EM, Sanda M, Hofer MD, Mertz KD, Paris PL, Simko J, Bismar TA, Ayala G, Shah RB, Loda M, Rubin MA. Mosquera JM, et al. Among authors: bismar ta. Clin Cancer Res. 2008 Jun 1;14(11):3380-5. doi: 10.1158/1078-0432.CCR-07-5194. Clin Cancer Res. 2008. PMID: 18519767 Free PMC article.

3

TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort.

Darnel AD, Lafargue CJ, Vollmer RT, Corcos J, Bismar TA. Darnel AD, et al. Among authors: bismar ta. Cancer Biol Ther. 2009 Jan;8(2):125-30. doi: 10.4161/cbt.8.2.7134. Epub 2009 Feb 4. Cancer Biol Ther. 2009. PMID: 19029822

4

A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer.

Alaoui-Jamali MA, Bismar TA, Gupta A, Szarek WA, Su J, Song W, Xu Y, Xu B, Liu G, Vlahakis JZ, Roman G, Jiao J, Schipper HM. Alaoui-Jamali MA, et al. Among authors: bismar ta. Cancer Res. 2009 Oct 15;69(20):8017-24. doi: 10.1158/0008-5472.CAN-09-0419. Epub 2009 Oct 6. Cancer Res. 2009. PMID: 19808972

5

PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer.

Bismar TA, Yoshimoto M, Vollmer RT, Duan Q, Firszt M, Corcos J, Squire JA. Bismar TA, et al. BJU Int. 2011 Feb;107(3):477-85. doi: 10.1111/j.1464-410X.2010.09470.x. BJU Int. 2011. PMID: 20590547

6

Detection of ERG gene rearrangements and PTEN deletions in unsuspected prostate cancer of the transition zone.

Liu S, Yoshimoto M, Trpkov K, Duan Q, Firszt M, Corcos J, Squire JA, Bismar TA. Liu S, et al. Among authors: bismar ta. Cancer Biol Ther. 2011 Mar 15;11(6):562-6. doi: 10.4161/cbt.11.6.14376. Epub 2011 Mar 15. Cancer Biol Ther. 2011. PMID: 21178509

7

Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer.

Bismar TA, Yoshimoto M, Duan Q, Liu S, Sircar K, Squire JA. Bismar TA, et al. Histopathology. 2012 Mar;60(4):645-52. doi: 10.1111/j.1365-2559.2011.04116.x. Epub 2012 Jan 19. Histopathology. 2012. PMID: 22260502

8

ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality.

Bismar TA, Dolph M, Teng LH, Liu S, Donnelly B. Bismar TA, et al. Eur J Cancer. 2012 Mar;48(4):538-46. doi: 10.1016/j.ejca.2012.01.001. Epub 2012 Feb 1. Eur J Cancer. 2012. PMID: 22300588

9

ERG protein expression and gene rearrangements are present at lower rates in metastatic and locally advanced castration-resistant prostate cancer compared to localized disease.

Teng LH, Wang C, Bégin LR, Dolph M, Yilmaz A, Trpkov K, Donnelly B, Bismar TA. Teng LH, et al. Among authors: bismar ta. Urology. 2013 Aug;82(2):394-9. doi: 10.1016/j.urology.2013.03.029. Epub 2013 Jun 6. Urology. 2013. PMID: 23746715

10

TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repair.

Dal Pra A, Lalonde E, Sykes J, Warde F, Ishkanian A, Meng A, Maloff C, Srigley J, Joshua AM, Petrovics G, van der Kwast T, Evans A, Milosevic M, Saad F, Collins C, Squire J, Lam W, Bismar TA, Boutros PC, Bristow RG. Dal Pra A, et al. Among authors: bismar ta. Clin Cancer Res. 2013 Sep 15;19(18):5202-9. doi: 10.1158/1078-0432.CCR-13-1049. Epub 2013 Aug 5. Clin Cancer Res. 2013. PMID: 23918607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page